Showing results (1-10 of 437) with videos related to
Sort By:
Pageof 44
Expert Review of Anti-Infective Therapy|October 28, 2011
Drug combinations for HIV: what's new?Andrew Scourfield, Laura Waters, Mark NelsonAIDS (London, England)|March 24, 2012
Discontinuation of Atripla as first-line therapy in HIV-1 infected individualsAndrew Scourfield, Jiexin Zheng, Suchitra Chinthapalli, et al.Expert Opinion on Pharmacotherapy|December 1, 2005
Cryptococcal disease and HIV infectionLaura Waters, Mark NelsonExpert Opinion on Investigational Drugs|May 16, 2007
The use of caspofungin in HIV-infected individualsLaura Waters, Mark NelsonCurrent Opinion in Infectious Diseases|November 1, 2006
New therapeutic options for hepatitis CLaura Waters, Mark NelsonAntiviral Research|March 10, 2010
Clinical outcome in resistant HIV-2 infection treated with raltegravir and maravirocDarius Armstrong-James, Justin Stebbing, Andrew Scourfield, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining eventsJustin Stebbing, Laura Waters, Sundhiya Mandalia, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
The risks and incidence of K65R and L74V mutations and subsequent virologic responsesLaura Waters, Mark Nelson, Sundhiya Mandalia, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patientsEugenia Vispo, Muge Cevik, Juergen K Rockstroh, et al.International Journal of Cancer|March 10, 2005
Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort studyLaura Waters, Justin Stebbing, Sundhiya Mandalia, et al.Pageof 44